The India GLP-1 receptor agonist market size was valued at USD 150.8 million in 2025 and is projected to grow from USD 240.5 million in 2026 to USD 1,004.9 million by 2033, at a CAGR of 22.7% from 2026 to 2033. The market is witnessing strong expansion, driven by the rising prevalence of... Read More »
June 2026The global hantavirus market size was valued at USD 64.8 million in 2025 and is projected to grow from USD 68.3 million in 2026 to USD 102.0 million by 2033, at a CAGR of 5.9% from 2026 to 2033. The North America Hantavirus market held the largest global share of 36.1% in 2025. The globa... Read More »
June 2026The global precision medicine market size was valued at USD 116.6 billion in 2025 and is projected to grow from USD 135.0 billion in 2026 to USD 405.1 billion by 2033, at a CAGR of 17.0% from 2026 to 2033. North America held the largest share of 52.25% of the global market in 2025. The i... Read More »
June 2026The global pharmaceutical contract manufacturing market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, at a CAGR of 10.4% from 2026 to 2033. North American paccounted for the largest share of 38.44% ... Read More »
June 2026The global psoriasis drugs market size was valued at USD 23.3 billion in 2025 and is projected to grow from USD 25.7 billion in 2026 to USD 54.9 billion by 2033, at a CAGR of 11.4% from 2026 to 2033. North America psoriasis drugs market held the largest share of 38.3% of the global marke... Read More »
June 2026The global autism spectrum disorder treatment market size was valued at USD 2.7 billion in 2025 and is projected to grow from USD 2.9 billion in 2026 to USD 4.4 billion by 2033, at a CAGR of 6.3% from 2026 to 2033. North America held the largest share of 51.8% of the global market in 202... Read More »
May 2026The global oligonucleotide therapeutics market size was valued at USD 7.2 billion in 2025 and is projected to grow from USD 8.6 billion in 2026 to USD 29.6 billion by 2033, at a CAGR of 19.4% from 2026 to 2033. The market in North America dominated with a revenue share of 47.6% in 2025. The industry is witnessing ra... Read More »
May 2026The global dupixent market size was valued at USD 15.2 billion in 2025 and is projected to grow from USD 16.4 billion in 2026 to USD 27.5 billion by 2033, at a CAGR of 7.7% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 75.2% in 2025. The market is witn... Read More »
May 2026The global specialty generics market size was valued at USD 96.0 billion in 2025 and is projected to grow from USD 102.8 billion in 2026 to USD 171.4 billion by 2033, at a CAGR of 7.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.9% in 2025.... Read More »
May 2026The U.S. medical foods market size was estimated at USD 6.9 billion in 2025 and is projected to reach USD 10.7 billion by 2033, growing at a CAGR of 5.5% 2026 to 2033. This growth is driven by the rising geriatric population, growing prevalence of chronic diseases, and increasing adoptio... Read More »
May 2026The Europe cannabidiol market size was estimated at USD 2.3 billion in 2025 and is projected to reach USD 6.0 billion by 2033, growing at a CAGR of 12.7% from 2026 to 2033. The industry is driven by the increasing legalization and regulatory clarity surrounding hemp-derived products acro... Read More »
May 2026The global excipients market size was estimated at USD 10,690.68 million in 2025 and is projected to reach USD 14,746.68 million by 2033, growing at a CAGR of 4.11% from 2026 to 2033. Excipients are increasingly valued for enhancing drug functionality and offering a competitive edge in f... Read More »
April 2026The global appetite stimulant market size was valued at USD 1.7 billion in 2025 and is projected to grow from USD 1.8 billion in 2026 to USD 2.9 billion by 2033, at a CAGR of 6.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.1% in 2025. The market addresses unmet n... Read More »
April 2026The U.S. vaccines market size was estimated at USD 26.00 billion in 2025 and is projected to reach USD 40.19 billion by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The U.S. vaccines market is driven by rapid advancements in vaccine technologies and platform innovation.... Read More »
April 2026The global complementary and alternative medicine for anti-aging & longevity market size was estimated at USD 99.56 billion in 2025 and is projected to reach USD 397.22 billion by 2033, growing at a CAGR of 18.34% from 2026 to 2033. The market is witnessing strong growth as individua... Read More »
April 2026The global neuropathic pain market size was valued at USD 8.5 billion in 2025 and is projected to grow from USD 9.1 billion in 2026 to USD 15.2 billion by 2033, at a CAGR of 7.5% from 2026 to 2033. The North America neuropathic pain market held the largest share of 37.9% of the global ma... Read More »
April 2026The Japan paroxysmal nocturnal hemoglobinuria treatment market was valued at USD 279.95 million in 2025 and is projected to reach USD 455.53 million by 2033, growing at a CAGR of 5.88% from 2026 to 2033. This growth is driven by continuous advancements in complement inhibitor therapies, ... Read More »
April 2026The New York legal cannabis market size was estimated at USD 2.52 billion in 2025 and is expected to reach USD 6.06 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market growth is driven by the legalization of cannabis, increasing awareness regarding the therape... Read More »
April 2026The South Africa traditional & complementary medicine market size was estimated at USD 1.40 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. The market represents a mature, system-driven healthcare segment characterized ... Read More »
March 2026The global alpha-gal syndrome allergy market size was valued at USD 78.0 million in 2025 and is projected to grow from USD 84.2 million in 2026 to USD 147.9 billion by 2033, at a CAGR of 8.4% from 2026 to 2033.North America alpha-gal syndrome allergy market held the largest share of 83.9... Read More »
February 2026